How many patients do you reach?
Clinical Trial Matcher is currently an early-stage public discovery platform with 17,146 active and upcoming trial records. Pilot discussions should treat reach as an experimental channel to validate patient intent, referral quality, and workflow fit rather than an already scaled recruitment network. For a pilot, we define expected reach by study area, target geography, search demand, and approved outreach assumptions.
What is the typical referral timeline?
After a patient submits interest, the platform stores the referral record and sends operational notifications through the approved routing workflow. For current workflows, patients are told the study team may contact them within 3-5 business days. A CRO pilot can define tighter or different site-response SLAs if participating sites agree.
What information do sites receive?
Referral payloads can include the patient's name, email, phone, preferred contact method, selected NCT ID, trial title, submission timestamp, optional notes, and basic eligibility confirmations shown in the form. The platform does not collect full medical records or make clinical eligibility determinations.
How do you verify patient eligibility?
Clinical Trial Matcher supports basic front-end eligibility confirmations based on the public trial listing, such as age or sex requirements when available. During a pilot, partner-approved prescreening questions can be added. Formal eligibility verification remains the responsibility of the participating research site and investigator.
What if a referred patient does not qualify?
Not every interested patient will qualify after site screening. The goal of the pilot is to measure referral quality through agreed metrics such as contact rate, prescreen completion, screen-fail reasons where shareable, and conversion to screening or enrollment. Non-qualifying referrals can be reviewed to refine messaging, geography, prescreening, and study fit.
Can we track referral outcomes?
Yes, outcome tracking can be configured for the pilot. Common fields include referral received, contact attempted, contact completed, prescreen completed, scheduled screening, screen failed, randomized/enrolled, and reason codes where appropriate. The practical implementation depends on how participating sites can provide feedback.
How is patient consent documented?
Submitting the trial interest form is treated as expressed interest and consent for follow-up about the selected study. Submission data is stored with a timestamp and study context. Pilot-specific consent language can be reviewed and updated with partner, site, sponsor, or IRB requirements.
Can the pilot support multiple sites?
Yes. A pilot can be configured around a single study, a subset of sites, or a specific geography. Routing logic and reporting should be defined before launch so referrals go to the correct site contact and outcomes can be reconciled consistently.
Is Clinical Trial Matcher HIPAA compliant?
Clinical Trial Matcher does not currently claim HIPAA certification. It is not representing itself as a covered entity. The platform follows HIPAA-aligned best practices for the pilot stage, including data minimization, encrypted transport, managed encrypted storage, limited access, and submission logging. Any BAA or covered-entity requirements should be reviewed as part of pilot contracting.
Ready to evaluate a focused pilot?
Share the study area, geography, participating sites, and desired success metrics so we can scope the workflow.